Table 3.
Diagnosis group | Turkish cases (n) | Non-Turkish cases (n) | PCIR (95% CI) |
Lymphoid leukaemia | 211 | 4430 | 1.02 (0.91–1.14) |
Acute non-lymphocytic leukemia | 49 | 870 | 1.21 (0.92–1.58) |
Hodgkin's disease | 41 | 708 | 1.24 (0.92–1.67) |
Non-Hodgkin/Burkitt Lymphoma | 44 | 736 | 1.28 (0.96–1.70) |
CNS tumors | 138 | 2944 | 1.00 (0.86–1.17) |
Neuroblastoma and ganglioneuroblastoma | 60 | 1327 | 0.97 (0.76–1.23) |
Retinoblastoma | 14 | 388 | 0.77 (0.46–1.30) |
Nephroblastoma | 42 | 1119 | 0.80 (0.60–1.08) |
Malignant bone tumours | 38 | 837 | 0.97 (0.71–1.32) |
Soft-tissue sarcomas | 36 | 1032 | 0.75 (0.54–1.03) |
Germ-cell tumors | 25 | 626 | 0.85 (0.58–1.26) |
Other | 34 | 646 | 1.13 (0.81–1.57) |
Total | 732 | 15663 | - |